New Technology– category –
-
ACM Research Secures Production and Evaluation Orders for Ultra ECP ap-p Horizontal Panel Electroplating Tool, Supporting 600x600mm Panels
GlobeNewswire USA Overview ACM Research announced securing production and evaluation orders from two advanced packaging customers for its Ultra ECP ap-p horizontal panel-level electroplating tool. This innovative tool supports large pane... -
AI’s Performance Breakthrough: Advanced Packaging, Power, and Interconnects Take Center Stage at SEMI Europe 2026
SEMI Europe Europe Overview SEMI Europe's 2026 Advanced Packaging Conference (APC) will spotlight 'Power and Interconnects Innovations Enabling AI System Performance,' emphasizing advanced packaging (AP) and test as crucial for scaling n... -
FDA Grants Fast Track and Priority Review to Multiple Cancer Drugs in July 2026: Insilico Medicine’s ISM6331 Receives Designation for Mesothelioma
Pharmacy Times USA Overview In July 2026, the FDA granted Fast Track Designation and Priority Review to several oncology therapeutics, targeting colorectal cancer, anal cancer, malignant pleural mesothelioma, and large B-cell lymphoma. N... -
Large Language Models Accelerate Small-Molecule Drug Discovery: Structure-Guided AI System “MolecularCanvas” Streamlines Generation and Evaluation
arXiv International Overview An interactive system named "MolecularCanvas," powered by Large Language Models (LLMs), has been developed to accelerate iterative molecular optimization in small-molecule drug discovery. This system guides t... -
Insilico Medicine Nominates ISM9077, Potential First-in-Class AI-Designed Target Y Inhibitor, as Preclinical Candidate for Ocular, Inflammatory, and Aging Disorders
Barchart.com (Insilico Medicine Press Release) Hong Kong Overview Insilico Medicine nominated ISM9077, a potential first-in-class Target Y inhibitor, as a preclinical candidate (PCC) for ocular diseases, inflammatory disorders, and aging... -
Daiichi Sankyo’s DXd ADC Pipeline Advances: ENHERTU Files for HER2-Low/Ultra-Low Breast Cancer, Dato-DXd Gains FDA Breakthrough Therapy for EGFRm NSCLC
Quartr Japan Overview Daiichi Sankyo reported significant progress in its DXd antibody-drug conjugate (ADC) pipeline, with ENHERTU showing efficacy in HER2-low and ultra-low breast cancer, leading to global regulatory submissions. Datopo... -
Converging Frontiers: MDPI Highlights Fusion of Synthetic and Natural Drug Research Reshaping Drug Discovery and DDS
MDPI Switzerland Overview An MDPI review highlights the convergence of synthetic chemistry and natural product research, alongside advancements in pharmaceutical engineering, biomaterials science, computational biology, and translational... -
Micron Biomedical Secures Microneedle Contract, AbbVie’s Maviret Gains EU Approval, and Moderna’s mRNA Pipeline Advances: Diverse Drug Delivery and Discovery Progress
Drug Discovery News USA Overview The drug discovery and delivery landscape sees diverse advancements: Micron Biomedical secured a $4.5 million NIAID contract for a microneedle patch for radiation injury, highlighting advancements in pain... -
GLP-1 Agonist Tirzepatide Significantly Reduces Cardiovascular Events and Infection Risk by One-Third in Type 2 Diabetes and Obesity Patients
Technical University of Munich Germany Overview A study published in The BMJ, conducted by researchers from the Technical University of Munich and Harvard Medical School, found that tirzepatide (Mounjaro), a GLP-1 agonist, significantly ... -
HKeyBio Launches HKEY-AI2Vivo™ 1.0 Program to Accelerate In Vivo Validation for AI-Designed Candidates, Addressing Pre-IND Bottlenecks
Drug Discovery Online USA Overview HKeyBio launched HKEY-AI2Vivo™ 1.0, an AI Candidate In Vivo Validation Acceleration Program, to support AI drug discovery teams in translating AI-generated targets and molecules into in vivo pharmacolog...
